NCT06145893: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease |
|
|
| Recruiting | 3 | 162 | RoW | Hemay005, Mufemilast, Phosphodiesterase 4 (PDE4) inhibitors, Placebo | Ganzhou Hemay Pharmaceutical Co., Ltd | Behçet's Disease | 11/24 | 03/25 | | |
NCT04957550: To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis |
|
|
| Enrolling by invitation | 3 | 444 | RoW | SHR0302 tablets、Placebo, Placebo | Jiangsu HengRui Medicine Co., Ltd. | Psoriatic Arthritis | 11/24 | 11/24 | | |